🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
We want to compare Taxol given weekly with Taxotere given every 3 week both...
Status
Completed
Location
Ullevål university hospital
Start Date
2005-03
Trial ID
NCT00201435
AMBRE is a phase III study comparing two standard treatments as initial met...
Status
Active Not Recruiting
Location
Centre Hospitalier Lyon Sud
Start Date
2020-06-11
Trial ID
NCT04158362
Researchers are looking for new ways to treat types of breast cancer that a...
Status
Recruiting
Location
Banner MD Anderson Cancer Center ( Site 0066)
Start Date
2025-06-30
Trial ID
NCT06966700
This study is an open-label, dose-escalation study of MM-111 with five diff...
Status
Completed
Location
Rocky Mountain Cancer Centers
Start Date
2011-01
Trial ID
NCT01304784
To determine the best dose of this investigational agent AG-013736 in combi...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2005-12
Trial ID
NCT00454649
Treatments Being Tested
This is a Phase III, 2-arm, randomised, open-label, multicentre, global stu...
Status
Active Not Recruiting
Location
Research Site
Start Date
2023-11-14
Trial ID
NCT06112379
This is a non-randomized, open-label, dose-escalation, and dose-expansion P...
Status
Active Not Recruiting
Location
Cancer Hospital of Shandong First Medical University
Start Date
2025-03-13
Trial ID
NCT06771622
This is an interventional, single arm, open-label, feasibility trial with g...
Status
Recruiting
Location
EBG MedAustron GmbH
Start Date
2020-09-14
Trial ID
NCT04894643
During this open label study patients will receive IMM-101 in conjunction w...
Status
Terminated
Location
Centre Léon Bérard, Dpt Medecine & INSERM
Start Date
2017-05-31
Trial ID
NCT03009058
This study will evaluate safety, pharmacodynamics and biomarkers of subcuta...
Status
Active Not Recruiting
Location
City of Hope
Start Date
2023-04-03
Trial ID
NCT05704985
Treatments Being Tested